Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
SANUWAVE Health, Inc. incurred revolving credit of $5.0 million secured revolving credit facility with JPMorgan Chase Bank, N.A., as administrative agent at term rate based upon the secured overnight financing rate (“SOFR”) plus a margin maturing September 25, 2027.
- Instrument
- revolving credit
- Principal
- $5.0 million secured revolving credit facility
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent
- Rate
- term rate based upon the secured overnight financing rate (“SOFR”) plus a margin
- Maturity
- September 25, 2027
- Event
- incurrence
Exact text from the filing
and a $5.0 million secured revolving credit facility (the "Revolver" and together with the Term Loan, the "Facility") that matures September 25, 2027
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
SANUWAVE Health, Inc. incurred credit facility of $23.0 million secured term loan with JPMorgan Chase Bank, N.A., as administrative agent at term rate based upon the secured overnight financing rate (“SOFR”) plus a margin maturing September 25, 2029.
- Instrument
- credit facility
- Principal
- $23.0 million secured term loan
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent
- Rate
- term rate based upon the secured overnight financing rate (“SOFR”) plus a margin
- Maturity
- September 25, 2029
- Event
- incurrence
Exact text from the filing
The Credit Agreement provides for a $23.0 million secured term loan (the "Term Loan") that matures September 25, 2029
View on SEC.gov